fintech-investing Dave Inc. Appoints Nima Khajehnouri to Board of Directors; Announces Board Leadership Transitions
fintech-investing Dave to Host Third Quarter 2025 Conference Call on November 4, 2025 at 8:30 a.m. ET
Genentech Announces Positive Phase II Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People Living With Obesity